BMRA
BIOMERICA INC
Key Financials
Operating Income
$-5320000
↓ 3.6%
Net Income
$-3775000
↑ 24.1%
EPS (Diluted)
$-1.30
↑ 39.8%
Total Liabilities
$4.1M
↑ 124.4%
Total Assets
$6.8M
↑ 13.7%
Shareholders' Equity
$2.6M
↓ 35.9%
Revenue
$4.5M
↓ 16.2%
Gross Profit
$362000
↓ 27.3%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 10-K/A | 9/28/2026 | View on SEC |
| S-3 | 9/24/2026 | View on SEC |
| S-3 | 9/24/2026 | View on SEC |
| 3 | 9/10/2026 | View on SEC |
| 3 | 9/8/2026 | View on SEC |
| 10-K | 8/31/2026 | View on SEC |
| SCHEDULE 13D | 8/28/2026 | View on SEC |
| 4 | 8/27/2026 | View on SEC |
| 4 | 8/27/2026 | View on SEC |
| 4 | 8/27/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | BMRA |
| Company Name | BIOMERICA INC |
| CIK | 73290 |
| Sector | In Vitro & In Vivo Diagnostic Substances |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | Nasdaq |
| SIC Code | 2835 |
| SIC Description | In Vitro & In Vivo Diagnostic Substances |
| Entity Type | operating |
| Fiscal Year End | 0531 |
| State of Incorporation | DE |
| Phone | 9493792875 |